Table 1.
Comparison of RA activity scores and radiological scores over follow-up according to the presence of FRA
| FRA | No FRA | Difference in adjusted scores | P-valuea | |
|---|---|---|---|---|
| DAS28 | 3.50 | 3.05 | 0.45 | <0.0001 |
| SDAI | 16.09 | 11.54 | 4.55 | <0.0001 |
| CDAI | 14.98 | 10.75 | 4.23 | <0.0001 |
| HAQ | 0.63 | 0.45 | 0.17 | 0.0002 |
| SJC | 2.32 | 2.18 | 0.14 | 0.5476 |
| TJC | 7.97 | 3.27 | 2.37 | 0.0001 |
| PtGH VAS | 3.82 | 3.01 | 0.81 | <0.0001 |
| PhGH VAS | 2.88 | 2.38 | 0.51 | 0.0044 |
| CRP | 0.75 | 0.84 | 0.09 | 0.4147 |
| ESR | 13.99 | 15.05 | 1.06 | 0.3602 |
| SHARP | 7.33 | 7.68 | 0.34 | 0.3125 |
aEstimates presented correspond to the least squares means using a mixed regression model including the 6-, 12- and 18-month visit, adjusting for baseline score, gender, age and smoking status. CDAI: Clinical Disease Activity Index; DAS28: 28-joint DAS; FRA: fibromyalgic RA; PhGH: physician global health; PtGH: patient global health; SDAI: Simplified Disease Activity Index; SHARP: Sharp–van der Heijde score; SJC: swollen joint count, TJC: tender joint count; VAS: visual analogue scale.